Topics

11/20/18

Cytocybernetics, a UB spinoff founded by two Jacobs School of Medicine and Biomedical Sciences faculty members, has received a $250,000 Small Business Innovation Research award from the National Institute of Mental Health (NIMH) to move into a new market: neuronal drug development.

3/16/17

Using a database of 16,000 brain scans, Robert S. Miletich, MD, PhD, interim chair and professor of nuclear medicine, is helping to develop the field of nuclear neurology, which could launch a revolution in the diagnosis and treatment of brain diseases.

5/31/16

Gabriela K. Popescu, PhD — with first author Kirstie A. Cummings, a candidate in the biochemistry doctoral program — has published a paper in Scientific Reports showing that an elusive brain receptor may play an important role in the death of neurons from neurological diseases.

2/5/16

Clinical trials conducted by Arie L. Weinstock, MD, clinical professor of neurology, are exploring the safety and effectiveness of medical marijuana treatments for epilepsy patients.